ReviewDisease markers2018
Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence.
Carmen Mecca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
72 papers cite itlatest 60 shown
this paperpooled itcites it
ReviewDisease markers2018
Carmen Mecca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.